TORONTO, April 16, 2018 (GLOBE NEWSWIRE) — Nutritional High International Inc. (the “Company” or “Nutritional High”) (CSE:EAT) (OTCQB:SPLIF) (FRANKFURT:2NU) is pleased to comment on President Trump’s favourable comments in support of a federally-led approach to cannabis regulation and the recent appointment of former House Speaker John Boehner to the advisory board of a private U.S. cannabis company. The Company believes these developments provide significant support to the U.S. cannabis market and signal potential positive developments ahead for the regulatory status of cannabis in the U.S.
On April 13, 2018, the Washington Post reported that President Trump and Colorado Senator Cory Gardner reached an understanding that the marijuana industry in Colorado will not be subject to interference from the federal government and that the Department of Justice’s recession of the Cole memo will not impact Colorado’s legal marijuana industry. In addition, Senator Gardner reported that during their conversations, President Trump asserted his belief that cannabis regulations are a states’ rights issue that should be determined without intervention from the federal government. Furthermore, President Trump provided assurances that he will support a federalism-based legislative solution to prevent future federal involvement in state-level cannabis regulation.
Two days’ prior, on April 11, 2018 it was reported that former Speaker of the House John Boehner was joining the advisory board of a private U.S cannabis company. Mr. Boehner was previously a staunch opponent of cannabis legalization in the U.S., but in a statement announcing his appointment he alluded to an evolution in his views based on a range of factors, including shifting public perception and the potential efficacy of cannabis use for treatment of medical ailments.
Jim Frazier, CEO of Nutritional High, commented, “We are very excited about both Speaker Boehner’s joining a U.S.-based cannabis company and President Trump’s recent favourable stance to cannabis regulation. We believe these developments serve as significant indications of changing perceptions towards cannabis in the U.S., and we look forward to the continuing evolution of the industry. Operating in a more favourable regulatory environment will bolster our operational and strategic objectives and should drive further value to our shareholders going forward.”